Within weeks, beyond what anyone had predicted, the experiment worked. The young man and two other patients began to regain some vision.
The results, reported online today by the New England Journal of Medicine, represent a dramatic advance in the field known as gene therapy, a field marked by sparkling - yet so far largely unfulfilled - promise.
The three patients, treated in a joint effort by the University of Pennsylvania and Children's Hospital of Philadelphia, remain legally blind. But there are indications that the procedure may work even better in children, and the lessons could one day apply to other forms of inherited blindness.
"This Philadelphia trial is exceptionally exciting," said Savio Woo, a gene-therapy specialist at the Mount Sinai School of Medicine who was not involved with the study. "It's absolutely remarkable."
The Inquirer followed the trial over eight months under the agreement that it would not print an account until the research was published in an academic journal.
The official goal of the surgery was to make sure such an injection was safe; no one promised the young man, who had flown from Italy for the experimental treatment, that he would see any better.
But luck was on his side.
Bennett and Maguire set the date of the surgery for Thursday, Dec. 13.
To them, it was just another day on the calendar. But to the Italian clinicians assisting in the operation, it was auspicious.
The 13th is the feast day of Santa Lucia, patron saint of the blind.
A 'simple problem'
Jean Bennett and Albert Maguire first talked about the eye idea as they were finishing up Harvard medical school in the mid-1980s - she exploring the fledgling field of genetics, he learning to be a surgeon.
